Skip to main content
Eurofins Scientific SE logo

Eurofins Scientific SE — Investor Relations & Filings

Ticker · ESF0 ISIN · FR0014000MR3 LEI · 529900JEHFM47DYY3S57 PA Professional, scientific and technical activities
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2026-02-04 Director's Dealing
Country LU Luxembourg
Listing PA ESF0

About Eurofins Scientific SE

https://www.eurofins.com/

Eurofins Scientific is a global group of laboratories providing a comprehensive range of analytical testing services. The company is a world leader in food, environmental, pharmaceutical, and cosmetic product testing. Its portfolio also extends to agroscience contract research organization (CRO) services and specialized offerings in discovery pharmacology, early-stage pharmaceutical development, central laboratory support, and biopharma product testing. Operating through an extensive international network of laboratories, Eurofins delivers bio-analytical services to ensure the safety, identity, purity, composition, and authenticity of a wide variety of products and substances for clients across numerous industries.

Recent filings

Filing Released Lang Actions
2026.02.04
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions by a Person Discharging Managerial Responsibilities (PDMR), specifically Analytical Bioventures S.C.A., which is controlled by the CEO of Eurofins Scientific S.E. The text explicitly follows the format required by the European Market Abuse Regulation for reporting insider dealings. This falls directly under the 'Director's Dealing' category.
2026-02-04 English
2026.02.03
Director's Dealing Classification · 1% confidence The document is a formal notification of a share transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically a director named Gavin Hill. It follows the standard format for 'Notification and Public Disclosure of Transactions' required under the European Market Abuse Regulation. This falls directly under the definition of 'Director's Dealing'.
2026-02-03 English
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Transaction in Own Shares Classification · 1% confidence The document is a weekly report detailing specific share repurchase transactions (dates, volumes, and weighted average prices) conducted by Eurofins Scientific. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share buyback disclosures.
2026-02-02 English
20260202
Transaction in Own Shares Classification · 1% confidence The document is a weekly report detailing specific share repurchase transactions (dates, volumes, and weighted average prices) conducted by Eurofins Scientific. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share buyback disclosures.
2026-02-02 English
Inside Information / News release on accounts, results
Earnings Release Classification · 1% confidence The document is a press release titled 'Eurofins delivers FY 2025 objectives', which provides preliminary unaudited financial results, key performance indicators (EPS, EBITDA, revenue, cash flow), and strategic outlooks. It explicitly states that it is a pre-publication of preliminary results and that the full audited Annual Report is expected to be published later (26 February 2026). As it is an initial announcement of financial results for a period, it fits the definition of an Earnings Release (ER). FY 2025
2026-01-29 English
Eurofins 2025 Full Year Results Press Release
Regulatory Filings
2026-01-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.